As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans ...
The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...
Most COVID-19 vaccine hesitancy is rooted in concerns that can be addressed and effectively reduced over time, according to a ...
News-Medical.Net on MSN
Long-term study reveals shifting patterns in COVID-19 vaccine hesitancy
Most COVID-19 vaccine hesitancy is rooted in concerns that can be addressed and effectively reduced over time, according to a ...
Infant protection against respiratory syncytial virus (RSV) by maternal RSV vaccination or receipt of RSV monoclonal antibody ...
Women and the elderly are more likely to be vaccine-hesitant, according to a study on Tuesday, which analysed data from more ...
The CDC never recommended babies get 72 injections . In 2024 and part of 2025, before the Trump administration’s changes, it recommended children up to age 2 get up to 12 different vaccines protecting ...
Houston Methodist, which Mary Bowden sued for defamation after it suspended her admitting privileges, "collects up to ...
Findings reveal a general decline in vaccine hesitancy during the 15 months following the COVID-19 vaccine roll-out in 2021-2022, with almost two-thirds of those initially hesitant going on to receive ...
A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...
Under the 2024 schedule, which has been discontinued, babies could have received anywhere from 12 to 30 shots before their second birthday ...
Analysts see greater upside in Novavax, while Moderna carries a ‘Hold’ rating despite stronger gains over the past year. ・Moderna was in focus after updated cancer vaccine data, while Novavax drew ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results